New activity is brewing for Sonnet BioTherapeutics Holdings ( ($SONN) ). The company has submitted a Form DEFM14A to the SEC, indicating an ...
Nasdaq-listed biotech firm Sonnet BioTherapeutics announced Monday a $888 million merger agreement with Rorschach I LLC, an entity formed by crypto businesses. The merger will change Sonnet’s focus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback